I’m about 7 months into tirzepatide, down 38 lbs, and I mostly track hunger, sleep, and whether my knees complain on stairs. Peptides keep popping up in my feed, and now there’s this FDA panel news about BPC-157 and compounding. I’m not using it, and I’m not rushing to. I’m just trying to figure out what actually changed: availability, safety warnings, pharmacy rules, or all three? I’m cautious because my body already gives me plenty of feedback on GLP-1, and I don’t want to add noise. If you’ve been reading about this, what sources helped you separate the actual regulatory update from internet panic? Gentle follow-up: did it change anything about how you talk to your prescriber?
👍 6
❤️ 1